80
Views
2
CrossRef citations to date
0
Altmetric
Original Research

The Combination of Neoadjuvant Therapy and Surgical Resection: A Safe and Effective Treatment for Rectal Gastrointestinal Stromal Tumors

, , , ORCID Icon, , , , , & show all
Pages 4671-4678 | Published online: 14 Jun 2021

References

  • Tran T , Davila JA , El-Serag HB . The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1458 cases from 1992 to 2000. Am J Gastroenterol . 2005;100(1):162–168. doi:10.1111/j.1572-0241.2005.40709.x 15654796
  • Ulanja MB , Rishi M , Beutler BD , et al. Racial disparity in incidence and survival for Gastrointestinal Stromal Tumors (GISTs): an analysis of SEER database. J Racial Ethn Health Disparities . 2019;6(5):1035–1043. doi:10.1007/s40615-019-00605-9 31215017
  • Bischof DA , Kim Y , Dodson R , et al. Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA Surg . 2015;150(4):299–306. doi:10.1001/jamasurg.2014.2881 25671681
  • von Mehren M , Randall RL , Benjamin RS , et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. JNCCN . 2018;16(5):536–563. doi:10.6004/jnccn.2018.0025 29752328
  • Casali PG , Abecassis N , Aro HT , et al. Gastrointestinal stromal tumours: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol . 2018;29(Suppl 4):iv267. doi:10.1093/annonc/mdy320 30188977
  • Yang Z , Guo W , Huang R , Hu M , Wang H , Wang H . Transanal versus nontransanal surgery for the treatment of primary rectal gastrointestinal stromal tumors: a 10-year experience in a high-volume center. Ann Transl Med . 2020;8(5):201. doi:10.21037/atm.2020.01.55 32309348
  • Wilkinson MJ , Fitzgerald JE , Strauss DC , et al. Surgical treatment of gastrointestinal stromal tumour of the rectum in the era of imatinib. Br J Surg . 2015;102(8):965–971. doi:10.1002/bjs.9818 25970743
  • Li YS , Li W , Zeng QS , Fu WH . Effect of the imatinib treatment regimen on the postoperative prognosis of patients with high-risk gastrointestinal stromal tumors. Onco Targets Ther . 2019;12:4713–4719. doi:10.2147/OTT.S198129 31354302
  • Tang S , Yin Y , Shen C , et al. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST). World J Surg Oncol . 2017;15(1):79. doi:10.1186/s12957-017-1143-2 28399894
  • Cavnar MJ , Wang L , Balachandran VP , et al. Rectal Gastrointestinal Stromal Tumor (GIST) in the era of imatinib: organ preservation and improved oncologic outcome. Ann Surg Oncol . 2017;24(13):3972–3980. doi:10.1245/s10434-017-6087-9 29058144
  • Kramp KH , Omer MG , Schoffski P , d’Hoore A . Sphincter sparing resection of a large obstructive distal rectal gastrointestinal stromal tumour after neoadjuvant therapy with imatinib (Glivec). BMJ Case Rep . 2015;2015:bcr2014207775–bcr2014207775. doi:10.1136/bcr-2014-207775
  • Fletcher CD , Berman JJ , Corless C , et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol . 2002;33(5):459–465. doi:10.1053/hupa.2002.123545 12094370
  • Rutkowski P , Bylina E , Wozniak A , et al. Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour - the impact of tumour rupture on patient outcomes. Eur J Surg Oncol . 2011;37(10):890–896. doi:10.1016/j.ejso.2011.06.005 21737227
  • Lo SS , Papachristou GI , Finkelstein SD , Conroy WP , Schraut WH , Ramanathan RK . Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case. Dis Colon Rectum . 2005;48(6):1316–1319. doi:10.1007/s10350-004-0922-3 15793646
  • Kenno S , Inagaki M , Funakoshi T , et al. [A case of rectal Gastrointestinal Stromal Tumor(GIST)treated with imatinib mesylate neoadjuvant therapy to preserve the anus]. Gan to Kagaku Ryoho . 2018;45(6):981–984. Japanese.30026427
  • Ebihara Y , Okushiba S , Kawarada Y , Kitashiro S , Katoh H , Kondo S . Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case. Surg Today . 2008;38(2):174–177. doi:10.1007/s00595-007-3585-6 18239881
  • Jakob J , Mussi C , Ronellenfitsch U , et al. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib. Ann Surg Oncol . 2013;20(2):586–592. doi:10.1245/s10434-012-2647-1 22965573
  • Tielen R , Verhoef C , van Coevorden F , et al. Surgical management of rectal gastrointestinal stromal tumors. J Surg Oncol . 2013;107(4):320–323. doi:10.1002/jso.23223 22806955
  • Machlenkin S , Pinsk I , Tulchinsky H , et al. The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour. Colorect Dis . 2011;13(10):1110–1115. doi:10.1111/j.1463-1318.2010.02442.x
  • Fujimoto Y , Akiyoshi T , Konishi T , Nagayama S , Fukunaga Y , Ueno M . Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis . 2014;29(1):111–116. doi:10.1007/s00384-013-1769-7 24018650
  • Huynh TK , Meeus P , Cassier P , et al. Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group. BMC Cancer . 2014;14:156. doi:10.1186/1471-2407-14-156 24597959
  • Liu H , Yan Z , Liao G , Yin H . Treatment strategy of rectal gastrointestinal stromal tumor (GIST). J Surg Oncol . 2014;109(7):708–713. doi:10.1002/jso.23562 24510506
  • Cohen MH , Farrell A , Justice R , Pazdur R . Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Oncologist . 2009;14(2):174–180. doi:10.1634/theoncologist.2008-0255 19193781
  • Eisenberg BL , Harris J , Blanke CD , et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol . 2009;99(1):42–47. doi:10.1002/jso.21160 18942073
  • Pai VD , Demenezes JL , Patil PS , Saklani AP . Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series. J Gastrointest Oncol . 2016;7(2):262–268. doi:10.3978/j.issn.2078-6891.2015.088 27034795
  • Guo W , Yang Z , Wei Y , et al. Radical excision versus local resection for primary rectal gastrointestinal stromal tumors. Cohort Study Int J Surg . 2020;77:190–197. doi:10.1016/j.ijsu.2020.03.068 32278104
  • Lee H , Gachabayov M , Dong X , Bergamaschi R . Robotic transabdominal excision of pelvic gastrointestinal stromal tumour - a video vignette. Colorect Dis . 2019;21(9):1099. doi:10.1111/codi.14681
  • Emoto S , Akiyoshi T , Fukata K , Nagasaki T , Fukunaga Y . Laparoscopic transabdominal dissection and transection of the distal rectum followed by local excision through the anus for rectal gastrointestinal stromal tumor. Dis Colon Rectum . 2020;63(11):e542. doi:10.1097/DCR.0000000000001814 33044297
  • Pantuso G , Macaione I , Taverna A , et al. Surgical treatment of primary gastrointestinal stromal tumors (GISTs): management and prognostic role of R1 resections. Am J Surg . 2020;220(2):359–364. doi:10.1016/j.amjsurg.2019.12.006 31862107
  • Hølmebakk T , Bjerkehagen B , Hompland I , Stoldt S , Boye K . Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. Br J Surg . 2019;106(4):419–426. doi:10.1002/bjs.11027 30507040
  • Gronchi A , Bonvalot S , Poveda Velasco A , et al. Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant imatinib. JAMA Surg . 2020;155(6):e200397. doi:10.1001/jamasurg.2020.0397 32236507
  • Ohshima K , Fujiya K , Nagashima T , et al. Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors. Cancer Sci . 2019;110(12):3821–3833. doi:10.1111/cas.14202 31553483
  • Zhou Z , Chen Z , Chen M , Wang R , Yin Y , Yao Y . Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon. Tumour Biol . 2014;35(5):4357–4362. doi:10.1007/s13277-013-1572-7 24375257
  • Jiaxin L , Peiyun Z , Zheng T , et al. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor. Aging (Albany NY) . 2020;12(12):11416–11430. doi:10.18632/aging.103204 32561689
  • Nishida T , Blay JY , Hirota S , Kitagawa Y , Kang YK . The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer . 2016;19(1):3–14. doi:10.1007/s10120-015-0526-8 26276366
  • Joensuu H , Wardelmann E , Sihto H , et al. Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: an exploratory analysis of a randomized clinical trial. JAMA Oncol . 2017;3(5):602–609. doi:10.1001/jamaoncol.2016.5751 28334365